{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T20:19:19Z","timestamp":1791404359150,"version":"4.3.3"},"reference-count":79,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,7,1]],"date-time":"2021-07-01T00:00:00Z","timestamp":1625097600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,7,1]],"date-time":"2021-07-01T00:00:00Z","timestamp":1625097600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,4,21]],"date-time":"2022-04-21T00:00:00Z","timestamp":1650499200000},"content-version":"am","delay-in-days":294,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,7,1]],"date-time":"2021-07-01T00:00:00Z","timestamp":1625097600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2021,7,1]],"date-time":"2021-07-01T00:00:00Z","timestamp":1625097600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2021,7,1]],"date-time":"2021-07-01T00:00:00Z","timestamp":1625097600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2021,7,1]],"date-time":"2021-07-01T00:00:00Z","timestamp":1625097600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2021,7,1]],"date-time":"2021-07-01T00:00:00Z","timestamp":1625097600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100000097","name":"National Center for Research Resources","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000097","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100001003","name":"Boehringer Ingelheim","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100001003","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100017931","name":"Cytori Therapeutics","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100017931","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000005","name":"U.S. Department of Defense","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000005","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000049","name":"National Institute on Aging","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000049","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000050","name":"National Heart, Lung, and Blood Institute","doi-asserted-by":"publisher","award":["1R03AG032631"],"award-info":[{"award-number":["1R03AG032631"]}],"id":[{"id":"10.13039\/100000050","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000050","name":"National Heart, Lung, and Blood Institute","doi-asserted-by":"publisher","award":["K23HL105787"],"award-info":[{"award-number":["K23HL105787"]}],"id":[{"id":"10.13039\/100000050","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000050","name":"National Heart, Lung, and Blood Institute","doi-asserted-by":"publisher","award":["N01-HV-68161"],"award-info":[{"award-number":["N01-HV-68161"]}],"id":[{"id":"10.13039\/100000050","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000050","name":"National Heart, Lung, and Blood Institute","doi-asserted-by":"publisher","award":["N01-HV-68162"],"award-info":[{"award-number":["N01-HV-68162"]}],"id":[{"id":"10.13039\/100000050","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000050","name":"National Heart, Lung, and Blood Institute","doi-asserted-by":"publisher","award":["N01-HV-68163"],"award-info":[{"award-number":["N01-HV-68163"]}],"id":[{"id":"10.13039\/100000050","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000050","name":"National Heart, Lung, and Blood Institute","doi-asserted-by":"publisher","award":["N01-HV-68164"],"award-info":[{"award-number":["N01-HV-68164"]}],"id":[{"id":"10.13039\/100000050","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000050","name":"National Heart, Lung, and Blood Institute","doi-asserted-by":"publisher","award":["R01 HL090957"],"award-info":[{"award-number":["R01 HL090957"]}],"id":[{"id":"10.13039\/100000050","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000050","name":"National Heart, Lung, and Blood Institute","doi-asserted-by":"publisher","award":["T32HL69751"],"award-info":[{"award-number":["T32HL69751"]}],"id":[{"id":"10.13039\/100000050","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000050","name":"National Heart, Lung, and Blood Institute","doi-asserted-by":"publisher","award":["U01 HL649141"],"award-info":[{"award-number":["U01 HL649141"]}],"id":[{"id":"10.13039\/100000050","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000050","name":"National Heart, Lung, and Blood Institute","doi-asserted-by":"publisher","award":["U01 HL649241"],"award-info":[{"award-number":["U01 HL649241"]}],"id":[{"id":"10.13039\/100000050","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000050","name":"National Heart, Lung, and Blood Institute","doi-asserted-by":"publisher","award":["U0164829"],"award-info":[{"award-number":["U0164829"]}],"id":[{"id":"10.13039\/100000050","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100018044","name":"Verily Life Sciences","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100018044","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100019688","name":"Department of Medicine, Georgetown University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100019688","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002973","name":"Daiichi-Sankyo","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002973","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004339","name":"Sanofi","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004339","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100008501","name":"East Carolina University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100008501","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100001796","name":"Gustavus and Louise Pfeiffer Research Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100001796","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100009821","name":"Society for Women\u2019s Health Research","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100009821","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100002429","name":"Amgen","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100002429","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004325","name":"AstraZeneca","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004325","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004334","name":"Merck","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004334","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100012227","name":"Ladies Hospital Aid Society","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100012227","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100013015","name":"Cedars-Sinai Medical Center","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100013015","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100017007","name":"Adelson Family Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100017007","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100017564","name":"Qmed","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100017564","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100006108","name":"National Center for Advancing Translational Sciences","doi-asserted-by":"publisher","award":["UL1TR000124"],"award-info":[{"award-number":["UL1TR000124"]}],"id":[{"id":"10.13039\/100006108","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004374","name":"Medtronic","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004374","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100005292","name":"Brigham and Women&apos;s Hospital","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100005292","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100005564","name":"Gilead Sciences","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100005564","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100006093","name":"Patient-Centered Outcomes Research Institute","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100006093","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100006775","name":"GE Healthcare","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100006775","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007698","name":"University of Florida","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007698","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100008322","name":"CSL Behring","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100008322","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["MO1-RR00425"],"award-info":[{"award-number":["MO1-RR00425"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["UM1 HL087366"],"award-info":[{"award-number":["UM1 HL087366"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["American Heart Journal"],"published-print":{"date-parts":[[2021,7]]},"DOI":"10.1016\/j.ahj.2021.03.011","type":"journal-article","created":{"date-parts":[[2021,3,18]],"date-time":"2021-03-18T22:18:27Z","timestamp":1616105907000},"page":"90-103","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":103,"special_numbering":"C","title":["Rationale and design of the Women's Ischemia Trial to Reduce Events in Nonobstructive CAD (WARRIOR) trial"],"prefix":"10.1016","volume":"237","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-7805-9577","authenticated-orcid":false,"given":"Eileen M.","family":"Handberg","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C. Noel Bairey","family":"Merz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rhonda M.","family":"Cooper-Dehoff","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Janet","family":"Wei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Conlon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Margaret C.","family":"Lo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"William","family":"Boden","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Susan M.","family":"Frayne","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Todd","family":"Villines","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John A.","family":"Spertus","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"William","family":"Weintraub","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patrick","family":"O'Malley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bernard","family":"Chaitman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leslee J.","family":"Shaw","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthew","family":"Budoff","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andre","family":"Rogatko","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carl J.","family":"Pepine","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ahj.2021.03.011_bib0001","doi-asserted-by":"crossref","first-page":"e56","DOI":"10.1161\/CIR.0000000000000659","article-title":"Heart disease and stroke statistics-2019 update: a report from the American Heart Association","volume":"139","author":"Benjamin","year":"2019","journal-title":"Circulation"},{"key":"10.1016\/j.ahj.2021.03.011_bib0002","doi-asserted-by":"crossref","first-page":"1273","DOI":"10.1161\/CIRCRESAHA.116.307547","article-title":"Cardiovascular disease in women: clinical perspectives","volume":"118","author":"Garcia","year":"2016","journal-title":"Circ Res"},{"key":"10.1016\/j.ahj.2021.03.011_bib0003","doi-asserted-by":"crossref","first-page":"997","DOI":"10.1161\/CIRCULATIONAHA.115.015293","article-title":"Coronary heart disease mortality declines in the United States from 1979 through 2011: evidence for stagnation in young adults, especially women","volume":"132","author":"Wilmot","year":"2015","journal-title":"Circulation"},{"key":"10.1016\/j.ahj.2021.03.011_bib0004","doi-asserted-by":"crossref","first-page":"1075","DOI":"10.1161\/CIRCULATIONAHA.116.024534","article-title":"Ischemia and No Obstructive Coronary Artery Disease (INOCA): developing evidence-based therapies and research agenda for the next decade","volume":"135","author":"Bairey Merz","year":"2017","journal-title":"Circulation"},{"key":"10.1016\/j.ahj.2021.03.011_bib0005","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1016\/S0735-1097(86)80456-9","article-title":"Seven year survival of patients with normal or near normal coronary arteriograms: a CASS registry study","volume":"7","author":"Kemp","year":"1986","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.ahj.2021.03.011_bib0006","doi-asserted-by":"crossref","first-page":"1934","DOI":"10.1056\/NEJMp020047","article-title":"Myocardial ischemia and the pains of the heart","volume":"346","author":"Panza","year":"2002","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ahj.2021.03.011_bib0007","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1001\/archinternmed.2009.50","article-title":"Adverse cardiovascular outcomes in women with nonobstructive coronary artery disease: a report from the women's ischemia syndrome evaluation study and the st james women take heart project","volume":"169","author":"Gulati","year":"2009","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.ahj.2021.03.011_bib0008","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.118.008868","article-title":"Ischemia and No Obstructive Coronary Artery Disease (INOCA): what is the risk?","volume":"7","author":"Herscovici","year":"2018","journal-title":"J Am Heart Assoc"},{"key":"10.1016\/j.ahj.2021.03.011_bib0009","doi-asserted-by":"crossref","first-page":"734","DOI":"10.1093\/eurheartj\/ehr331","article-title":"Stable angina pectoris with no obstructive coronary artery disease is associated with increased risks of major adverse cardiovascular events","volume":"33","author":"Jespersen","year":"2012","journal-title":"Eur Heart J"},{"key":"10.1016\/j.ahj.2021.03.011_bib0010","doi-asserted-by":"crossref","first-page":"2993","DOI":"10.1161\/01.CIR.0000130642.79868.B2","article-title":"Prognosis in women with myocardial ischemia in the absence of obstructive coronary disease: results from the National Institutes of Health-National Heart, Lung, and Blood Institute-Sponsored Women's Ischemia Syndrome Evaluation (WISE)","volume":"109","author":"Johnson","year":"2004","journal-title":"Circulation"},{"key":"10.1016\/j.ahj.2021.03.011_bib0011","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCOUTCOMES.116.003863","article-title":"Ten-year mortality in the WISE study (Women's Ischemia Syndrome Evaluation)","volume":"10","author":"Kenkre","year":"2017","journal-title":"Circ Cardiovasc Qual Outcomes"},{"key":"10.1016\/j.ahj.2021.03.011_bib0012","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/j.ahj.2013.03.015","article-title":"Sex differences in clinical outcomes in patients with stable angina and no obstructive coronary artery disease","volume":"166","author":"Sedlak","year":"2013","journal-title":"Am Heart J"},{"key":"10.1016\/j.ahj.2021.03.011_bib0013","doi-asserted-by":"crossref","first-page":"1044","DOI":"10.1161\/CIRCULATIONAHA.115.015553","article-title":"Multiple causes for ischemia without obstructive coronary artery disease: not a short list","volume":"131","author":"Pepine","year":"2015","journal-title":"Circulation"},{"key":"10.1016\/j.ahj.2021.03.011_bib0014","doi-asserted-by":"crossref","first-page":"1408","DOI":"10.1093\/eurheartj\/ehl040","article-title":"Persistent chest pain predicts cardiovascular events in women without obstructive coronary artery disease: results from the NIH-NHLBI-sponsored Women's Ischaemia Syndrome Evaluation (WISE) study","volume":"27","author":"Johnson","year":"2006","journal-title":"Eur Heart J"},{"key":"10.1016\/j.ahj.2021.03.011_bib0015","doi-asserted-by":"crossref","first-page":"894","DOI":"10.1161\/CIRCULATIONAHA.105.609990","article-title":"The economic burden of angina in women with suspected ischemic heart disease: results from the National Institutes of Health\u2013National Heart, Lung, and Blood Institute\u2013sponsored Women's Ischemia Syndrome Evaluation","volume":"114","author":"Shaw","year":"2006","journal-title":"Circulation"},{"key":"10.1016\/j.ahj.2021.03.011_bib0016","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1253\/circj.CJ-16-1002","article-title":"Coronary microvascular dysfunction- epidemiology, pathogenesis, prognosis, diagnosis, risk factors and therapy","volume":"81","author":"Chen","year":"2016","journal-title":"Circ J"},{"key":"10.1016\/j.ahj.2021.03.011_bib0017","doi-asserted-by":"crossref","first-page":"888","DOI":"10.1016\/j.amjcard.2017.12.025","article-title":"Pharmacologic treatment of patients with myocardial ischemia with no obstructive coronary artery disease","volume":"121","author":"Turgeon","year":"2018","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.ahj.2021.03.011_bib0018","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.119.013234","article-title":"Predicted versus observed major adverse cardiac event risk in women with evidence of ischemia and no obstructive coronary artery disease: A report from WISE (Women's Ischemia Syndrome Evaluation)","volume":"9","author":"Sedlak","year":"2020","journal-title":"J Am Heart Assoc"},{"key":"10.1016\/j.ahj.2021.03.011_bib0019","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1007\/s00392-013-0568-z","article-title":"Persistent angina: highly prevalent and associated with long-term anxiety, depression, low physical functioning, and quality of life in stable angina pectoris","volume":"102","author":"Jespersen","year":"2013","journal-title":"Clin Res Cardiol"},{"key":"10.1016\/j.ahj.2021.03.011_bib0020","doi-asserted-by":"crossref","first-page":"640","DOI":"10.1161\/CIRCOUTCOMES.114.000967","article-title":"Development and validation of a short version of the Seattle Angina Questionnaire","volume":"7","author":"Chan","year":"2014","journal-title":"Circ Cardiovasc Qual Outcomes"},{"key":"10.1016\/j.ahj.2021.03.011_bib0021","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1016\/0735-1097(94)00397-9","article-title":"Development and evaluation of the Seattle Angina Questionnaire: a new functional status measure for coronary artery disease","volume":"25","author":"Spertus","year":"1995","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.ahj.2021.03.011_bib0022","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1002\/jts.22059","article-title":"The Posttraumatic Stress Disorder Checklist for DSM-5 (PCL-5): development and initial psychometric evaluation","volume":"28","author":"Blevins","year":"2015","journal-title":"J Trauma Stress"},{"key":"10.1016\/j.ahj.2021.03.011_bib0023","series-title":"Beck Depression Inventory-II [database record]","author":"Beck","year":"1996"},{"key":"10.1016\/j.ahj.2021.03.011_bib0024","doi-asserted-by":"crossref","first-page":"2825","DOI":"10.1016\/j.jacc.2010.01.054","article-title":"Coronary microvascular reactivity to adenosine predicts adverse outcome in women evaluated for suspected ischemia results from the National Heart, Lung and Blood Institute WISE (Women's Ischemia Syndrome Evaluation) study","volume":"55","author":"Pepine","year":"2010","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.ahj.2021.03.011_bib0025","doi-asserted-by":"crossref","first-page":"722","DOI":"10.1161\/01.CIR.0000115525.92645.16","article-title":"Abnormal coronary vasomotion as a prognostic indicator of cardiovascular events in women: results from the National Heart, Lung, and Blood Institute-Sponsored Women's Ischemia Syndrome Evaluation (WISE)","volume":"109","author":"von Mering","year":"2004","journal-title":"Circulation"},{"key":"10.1016\/j.ahj.2021.03.011_bib0026","doi-asserted-by":"crossref","first-page":"2518","DOI":"10.1161\/CIRCULATIONAHA.113.008507","article-title":"Effects of sex on coronary microvascular dysfunction and cardiac outcomes","volume":"129","author":"Murthy","year":"2014","journal-title":"Circulation"},{"key":"10.1016\/j.ahj.2021.03.011_bib0027","doi-asserted-by":"crossref","first-page":"840","DOI":"10.1093\/eurheartj\/ehx721","article-title":"Coronary microvascular dysfunction and future risk of heart failure with preserved ejection fraction","volume":"39","author":"Taqueti","year":"2018","journal-title":"Eur Heart J"},{"key":"10.1016\/j.ahj.2021.03.011_bib0028","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1016\/j.mayocp.2016.11.016","article-title":"Prevalence and prognosis of nonobstructive coronary artery disease in patients undergoing coronary angiography or coronary computed tomography angiography: a meta-analysis","volume":"92","author":"Wang","year":"2017","journal-title":"Mayo Clin Proc"},{"key":"10.1016\/j.ahj.2021.03.011_bib0029","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1016\/j.jchf.2018.12.018","article-title":"Is cardiac diastolic dysfunction a part of post-menopausal syndrome?","volume":"7","author":"Maslov","year":"2019","journal-title":"JACC Heart Fail"},{"key":"10.1016\/j.ahj.2021.03.011_bib0030","doi-asserted-by":"crossref","first-page":"1465","DOI":"10.1093\/eurheartj\/ehr047","article-title":"Prognostic value of cardiac hybrid imaging integrating single-photon emission computed tomography with coronary computed tomography angiography","volume":"32","author":"Pazhenkottil","year":"2011","journal-title":"Eur Heart J"},{"key":"10.1016\/j.ahj.2021.03.011_bib0031","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1016\/j.jacc.2010.11.078","article-title":"Mortality risk in symptomatic patients with nonobstructive coronary artery disease: a prospective 2-center study of 2,583 patients undergoing 64-detector row coronary computed tomographic angiography","volume":"58","author":"Lin","year":"2011","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.ahj.2021.03.011_bib0032","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1016\/j.jacc.2008.10.043","article-title":"Prognostic value of multislice computed tomography and gated single-photon emission computed tomography in patients with suspected coronary artery disease","volume":"53","author":"van Werkhoven","year":"2009","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.ahj.2021.03.011_bib0033","doi-asserted-by":"crossref","first-page":"1331","DOI":"10.1093\/eurheartj\/ehr009","article-title":"Are we using cardiovascular medications and coronary angiography appropriately in men and women with chest pain?","volume":"32","author":"Johnston","year":"2011","journal-title":"Eur Heart J"},{"key":"10.1016\/j.ahj.2021.03.011_bib0034","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1016\/j.jcmg.2008.12.031","article-title":"Diagnostic and prognostic value of absence of coronary artery calcification","volume":"2","author":"Sarwar","year":"2009","journal-title":"JACC Cardiovasc Imaging"},{"key":"10.1016\/j.ahj.2021.03.011_bib0035","doi-asserted-by":"crossref","first-page":"1505","DOI":"10.1016\/j.jacc.2005.01.040","article-title":"Positron emission tomography-measured abnormal responses of myocardial blood flow to sympathetic stimulation are associated with the risk of developing cardiovascular events","volume":"45","author":"Schindler","year":"2005","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.ahj.2021.03.011_bib0036","doi-asserted-by":"crossref","first-page":"1030","DOI":"10.1016\/j.jcmg.2010.07.008","article-title":"Prognostic value of global MR myocardial perfusion imaging in women with suspected myocardial ischemia and no obstructive coronary disease: results from the NHLBI-sponsored WISE (Women's Ischemia Syndrome Evaluation) study","volume":"3","author":"Doyle","year":"2010","journal-title":"JACC Cardiovasc Imaging"},{"key":"10.1016\/j.ahj.2021.03.011_bib0037","doi-asserted-by":"crossref","first-page":"1462","DOI":"10.1016\/S0735-1097(99)00076-5","article-title":"Pilot phase data from the National Heart, Lung and Blood Institute Women's Ischemia Syndrome Evaluation (WISE)","volume":"33","author":"Lewis","year":"1999","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.ahj.2021.03.011_bib0038","doi-asserted-by":"crossref","first-page":"E1486","DOI":"10.1016\/S0735-1097(12)61487-9","article-title":"Clinical outcomes in patients < 65 years with no obstructive coronary disease on coronary angiogram","volume":"59","author":"Sedlak","year":"2012","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.ahj.2021.03.011_bib0039","doi-asserted-by":"crossref","first-page":"e93170","DOI":"10.1371\/journal.pone.0093170","article-title":"Burden of hospital admission and repeat angiography in angina pectoris patients with and without coronary artery disease: a registry-based cohort study","volume":"9","author":"Jespersen","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.ahj.2021.03.011_bib0040","doi-asserted-by":"crossref","first-page":"2103","DOI":"10.1056\/NEJMoa1511939","article-title":"A randomized trial of intensive versus standard blood-pressure control","volume":"373","author":"Group","year":"2015","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ahj.2021.03.011_bib0041","doi-asserted-by":"crossref","first-page":"2805","DOI":"10.1001\/jama.290.21.2805","article-title":"A calcium antagonist vs a non-calcium antagonist hypertension treatment strategy for patients with coronary artery disease. The International Verapamil-Trandolapril Study (INVEST): a randomized controlled trial","volume":"290","author":"Pepine","year":"2003","journal-title":"JAMA"},{"key":"10.1016\/j.ahj.2021.03.011_bib0042","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1002\/clc.22145","article-title":"Mortality implications of angina and blood pressure in hypertensive patients with coronary artery disease: New data from extended follow-up of the International Verapamil\/Trandolapril Study (INVEST)","volume":"36","author":"Winchester","year":"2013","journal-title":"Clin Cardiol"},{"key":"10.1016\/j.ahj.2021.03.011_bib0043","doi-asserted-by":"crossref","first-page":"2037","DOI":"10.1161\/01.CIR.95.8.2037","article-title":"Asymptomatic Cardiac Ischemia Pilot (ACIP) study two-year follow-up: outcomes of patients randomized to initial strategies of medical therapy versus revascularization","volume":"95","author":"Davies","year":"1997","journal-title":"Circulation"},{"key":"10.1016\/j.ahj.2021.03.011_bib0044","doi-asserted-by":"crossref","first-page":"1670","DOI":"10.1016\/S0140-6736(10)61350-5","article-title":"Efficacy and safety of more intensive lowering of LDL cholesterol: a meta-analysis of data from 170,000 participants in 26 randomised trials","volume":"376","author":"Baigent","year":"2010","journal-title":"Lancet"},{"key":"10.1016\/j.ahj.2021.03.011_bib0045","doi-asserted-by":"crossref","first-page":"2195","DOI":"10.1056\/NEJMoa0807646","article-title":"Rosuvastatin to prevent vascular events in men and women with elevated C-reactive protein","volume":"359","author":"Ridker","year":"2008","journal-title":"N Engl J Med"},{"issue":"21 Suppl","key":"10.1016\/j.ahj.2021.03.011_bib0046","first-page":"A14414","article-title":"Treated hypertension and risk for cardiovascular events in women. The NHLBI-sponsored Women's Ischemia Syndrome Evaluation (WISE)","volume":"124","author":"Johnson","year":"2011","journal-title":"Circulation"},{"key":"10.1016\/j.ahj.2021.03.011_bib0047","doi-asserted-by":"crossref","first-page":"678","DOI":"10.1016\/j.ahj.2011.07.011","volume":"162","author":"Pauly","year":"2011","journal-title":"Am Heart J"},{"key":"10.1016\/j.ahj.2021.03.011_bib0048","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1161\/hc3001.093502","article-title":"Effects of ramipril on coronary events in high-risk persons: results of the Heart Outcomes Prevention Evaluation Study","volume":"104","author":"Dagenais","year":"2001","journal-title":"Circulation"},{"key":"10.1016\/j.ahj.2021.03.011_bib0049","doi-asserted-by":"crossref","first-page":"826","DOI":"10.1016\/j.ahj.2014.01.017","article-title":"Aldosterone inhibition and coronary endothelial function in women without obstructive coronary artery disease: an ancillary study of the National Heart, Lung, and Blood Institute-sponsored Women's Ischemia Syndrome Evaluation","volume":"167","author":"Bavry","year":"2014","journal-title":"Am Heart J"},{"key":"10.1016\/j.ahj.2021.03.011_bib0050","doi-asserted-by":"crossref","first-page":"2049","DOI":"10.1016\/j.jacc.2003.07.027","article-title":"Effects of angiotensin-converting enzyme inhibition on transient ischemia: the Quinapril Anti-Ischemia and Symptoms of Angina Reduction (QUASAR) trial","volume":"42","author":"Pepine","year":"2003","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.ahj.2021.03.011_bib0051","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1001\/jama.2020.9972","article-title":"Admissions to Veterans Affairs hospitals for emergency conditions during the COVID-19 pandemic","volume":"324","author":"Baum","year":"2020","journal-title":"JAMA"},{"key":"10.1016\/j.ahj.2021.03.011_bib0052","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1056\/NEJMc2015630","article-title":"The Covid-19 pandemic and the incidence of acute myocardial infarction","volume":"383","author":"Solomon","year":"2020","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ahj.2021.03.011_bib0053","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1016\/j.jacc.2020.05.038","article-title":"Fewer hopitalizations for acute cardiovascular conditions during the COVID-19 pandemic","volume":"76","author":"Bhatt","year":"2020","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.ahj.2021.03.011_bib0054","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/j.jacc.2020.10.055","article-title":"Cardiovascular deaths during the COVID-19 pandemic in the United States","volume":"77","author":"Wadhera","year":"2021","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.ahj.2021.03.011_bib0055","doi-asserted-by":"crossref","first-page":"185","DOI":"10.2307\/2344317","article-title":"Asymptotically efficient rank invariant test procedures","volume":"135","author":"Peto","year":"1972","journal-title":"J Royal Stat Soc"},{"key":"10.1016\/j.ahj.2021.03.011_bib0056","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1586\/14737167.6.3.337","article-title":"Statistical analysis of cost-effectiveness data from randomized clinical trials","volume":"6","author":"Willan","year":"2006","journal-title":"Expert Rev Pharmacoecon Outcomes Res"},{"key":"10.1016\/j.ahj.2021.03.011_bib0057","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1111\/j.1524-4733.2004.75013.x","article-title":"Estimating survival for cost-effectiveness analyses: a case study in atherothrombosis","volume":"7","author":"Caro","year":"2004","journal-title":"Value Health"},{"key":"10.1016\/j.ahj.2021.03.011_bib0058","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1053\/euhj.2001.2838","article-title":"A cardiovascular life history. A life course analysis of the original Framingham Heart Study cohort","volume":"23","author":"Peeters","year":"2002","journal-title":"Eur Heart J"},{"key":"10.1016\/j.ahj.2021.03.011_bib0059","series-title":"An introduction to the Bootstrap","author":"Efron","year":"1993"},{"key":"10.1016\/j.ahj.2021.03.011_bib0060","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1111\/j.1467-9868.2004.05304.x","article-title":"Probabilistic sensitivity analysis of complex models: a Bayesian approach","volume":"66","author":"Oakley","year":"2004","journal-title":"J Royal Stat Soc"},{"key":"10.1016\/j.ahj.2021.03.011_bib0061","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1161\/CIRCOUTCOMES.108.798462","article-title":"Cost-effectiveness of percutaneous coronary intervention in optimally treated stable coronary patients","volume":"1","author":"Weintraub","year":"2008","journal-title":"Circ Cardiovasc Qual Outcomes"},{"key":"10.1016\/j.ahj.2021.03.011_bib0062","doi-asserted-by":"crossref","first-page":"1503","DOI":"10.1056\/NEJMoa070829","article-title":"Optimal medical therapy with or without PCI for stable coronary disease","volume":"356","author":"Boden","year":"2007","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ahj.2021.03.011_bib0063","doi-asserted-by":"crossref","first-page":"2375","DOI":"10.1056\/NEJMoa1211585","article-title":"Strategies for multivessel revascularization in patients with diabetes","volume":"367","author":"Farkouh","year":"2012","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ahj.2021.03.011_bib0064","doi-asserted-by":"crossref","first-page":"2503","DOI":"10.1056\/NEJMoa0805796","article-title":"A randomized trial of therapies for type 2 diabetes and coronary artery disease. The BARI 2D Study Group","volume":"360","author":"Frye","year":"2009","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ahj.2021.03.011_bib0065","doi-asserted-by":"crossref","first-page":"1348","DOI":"10.1016\/j.jacc.2009.10.062","article-title":"Intensive multifactorial intervention for stable coronary artery disease: optimal medical therapy in the COURAGE (Clinical Outcomes Utilizing Revascularization and Aggressive Drug Evaluation) trial","volume":"55","author":"Maron","year":"2010","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.ahj.2021.03.011_bib0066","doi-asserted-by":"crossref","first-page":"1395","DOI":"10.1056\/NEJMoa1915922","article-title":"Initial invasive or conservative strategy for stable coronary disease","volume":"382","author":"Maron","year":"2020","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ahj.2021.03.011_bib0067","first-page":"16","article-title":"Low-potency statins initiatied in high-risk patients in a managed care setting. Value-Based Care in Cardiometabolic","volume":"1","author":"Kuznar","year":"2012","journal-title":"Health"},{"key":"10.1016\/j.ahj.2021.03.011_bib0068","doi-asserted-by":"crossref","first-page":"1504","DOI":"10.1093\/eurheartj\/ehv647","article-title":"A randomized, placebo-controlled trial of late Na current inhibition (ranolazine) in coronary microvascular dysfunction (CMD): impact on angina and myocardial perfusion reserve","volume":"37","author":"Bairey Merz","year":"2016","journal-title":"Eur Heart J"},{"key":"10.1016\/j.ahj.2021.03.011_bib0069","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1016\/j.jcmg.2019.04.021","article-title":"Preventive management of nonobstructive CAD after coronary CT angiography in the emergency department","volume":"13","author":"Honigberg","year":"2020","journal-title":"JACC Cardiovasc Imaging"},{"key":"10.1016\/j.ahj.2021.03.011_bib0070","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1161\/CIRCIMAGING.113.001564","article-title":"Coronary artery disease detected by coronary computed tomographic angiography is associated with intensification of preventive medical therapy and lower low-density lipoprotein cholesterol","volume":"7","author":"Hulten","year":"2014","journal-title":"Circ Cardiovasc Imaging"},{"key":"10.1016\/j.ahj.2021.03.011_bib0071","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1161\/CIRCOUTCOMES.110.957308","article-title":"Blood pressure trajectories and associations with treatment intensification, medication adherence, and outcomes among newly diagnosed coronary artery disease patients","volume":"3","author":"Maddox","year":"2010","journal-title":"Circ Cardiovasc Qual Outcomes"},{"key":"10.1016\/j.ahj.2021.03.011_bib0072","doi-asserted-by":"crossref","first-page":"1754","DOI":"10.1001\/jama.2014.14681","article-title":"Nonobstructive coronary artery disease and risk of myocardial infarction","volume":"312","author":"Maddox","year":"2014","journal-title":"JAMA"},{"key":"10.1016\/j.ahj.2021.03.011_bib0074","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1016\/j.ahj.2013.04.002","volume":"166","author":"Sharaf","year":"2013","journal-title":"Am Heart J"},{"key":"10.1016\/j.ahj.2021.03.011_bib0075","doi-asserted-by":"crossref","first-page":"1239","DOI":"10.1161\/CIRCULATIONAHA.111.029660","volume":"124","author":"Shaw","year":"2011","journal-title":"Circulation"},{"key":"10.1016\/j.ahj.2021.03.011_bib0076","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCIMAGING.114.002481","article-title":"Cardiac magnetic resonance myocardial perfusion reserve index is reduced in women with coronary microvascular dysfunction. A National Heart, Lung, and Blood Institute-sponsored study from the Women's Ischemia Syndrome Evaluation","volume":"8","author":"Thomson","year":"2015","journal-title":"Circ Cardiovasc Imaging"},{"key":"10.1016\/j.ahj.2021.03.011_bib0077","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1161\/CIRCULATIONAHA.112.000500","article-title":"Blood pressure and cholesterol control in hypertensive hypercholesterolemic patients: National Health and Nutrition Examination Surveys 1988\u20132010","volume":"128","author":"Egan","year":"2013","journal-title":"Circulation"},{"key":"10.1016\/j.ahj.2021.03.011_bib0078","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.117.007526","article-title":"Variations in use of optimal medical therapy in patients with nonobstructive coronary artery disease: a population-based study","volume":"6","author":"Oxner","year":"2017","journal-title":"J Am Heart Assoc"},{"key":"10.1016\/j.ahj.2021.03.011_bib0079","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/j.jcin.2019.11.001","article-title":"1-Year outcomes of angina management guided by invasive coronary function testing (CorMicA)","volume":"13","author":"Ford","year":"2020","journal-title":"JACC Cardiovasc Interv"},{"key":"10.1016\/j.ahj.2021.03.011_bib0080","doi-asserted-by":"crossref","first-page":"E2880","DOI":"10.3390\/jcm9092880","article-title":"Coronary microvascular dysfunction","volume":"9","author":"Vancheri","year":"2020","journal-title":"J Clin Med"}],"container-title":["American Heart Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002870321000776?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002870321000776?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,2]],"date-time":"2025-11-02T09:58:03Z","timestamp":1762077483000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0002870321000776"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,7]]},"references-count":79,"alternative-id":["S0002870321000776"],"URL":"https:\/\/doi.org\/10.1016\/j.ahj.2021.03.011","relation":{},"ISSN":["0002-8703"],"issn-type":[{"value":"0002-8703","type":"print"}],"subject":[],"published":{"date-parts":[[2021,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Rationale and design of the Women's Ischemia Trial to Reduce Events in Nonobstructive CAD (WARRIOR) trial","name":"articletitle","label":"Article Title"},{"value":"American Heart Journal","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ahj.2021.03.011","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}